+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Biopsy Needles Market by Type, Procedure, Category, Material, Purchasing Channel, Application, End User - Global Forecast to 2030

  • PDF Icon

    Report

  • 189 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6083296
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Biopsy Needles Market grew from USD 735.49 million in 2024 to USD 777.71 million in 2025. It is expected to continue growing at a CAGR of 5.81%, reaching USD 1.03 billion by 2030.

Pioneering Precision in Biopsy Needle Markets

Biopsy needles sit at the heart of diagnostic medicine, enabling clinicians to obtain actionable tissue samples with minimal invasiveness. As cancer incidence continues to rise globally, the demand for precise, reliable needles has soared. Innovations in needle design and materials have ushered in a new era of procedural accuracy. Clinicians now rely on advanced devices that support real-time imaging guidance and minimize tissue trauma, improving patient outcomes and accelerating diagnostic workflows.

The evolving landscape of healthcare has placed a premium on tools that can adapt to diverse clinical environments. Whether in tertiary hospitals, outpatient centers or specialized diagnostic clinics, practitioners require needles that deliver consistent performance under varying procedural protocols. Today’s market responds to calls for disposability, sterilization efficiency and operator ergonomics, reflecting a shift toward streamlined care pathways.

This report delves into the forces shaping the biopsy needle sector, from technological breakthroughs to regulatory pressures. It maps out how tariff adjustments will influence supply chains, unpacks nuanced segmentation factors, and highlights regional trends. Industry leaders will find strategic direction grounded in robust research methodology, enabling informed decisions that align with emerging opportunities and risks.

Evolving Dynamics Redefining Clinical Biopsy Approaches

Recent years have witnessed a convergence of imaging and interventional technologies that redefine the clinical biopsy workflow. High-resolution ultrasound, CT and MRI systems now interface seamlessly with needle guidance platforms, enabling real-time visualization and precise sampling of suspect lesions. Concurrent advances in artificial intelligence support automated target recognition and needle path planning, reducing procedure times and improving diagnostic yield. The result is a shift from manual techniques to data-driven interventions that elevate procedural consistency.

Alongside technological strides, evolving regulatory frameworks and reimbursement models exert significant influence on device design and adoption rates. Regulatory bodies increasingly emphasize device safety and traceability, driving manufacturers to implement robust quality management systems and transparent supply chains. Reimbursement policies that favor value-based care incentivize devices that deliver demonstrable improvements in patient throughput and outcomes, encouraging innovation in cost-effective, high-performance needle solutions.

Patient-centered considerations are reshaping material science and ergonomics in the biopsy needle domain. The incorporation of biocompatible polymers and coatings reduces friction and tissue trauma, while modular handle designs enhance operator control and comfort. Single-use configurations address infection control imperatives, and environmentally responsible packaging fulfills sustainability mandates. These design priorities align with broader institutional goals of risk mitigation and patient satisfaction.

Market dynamics are further influenced by digital connectivity and service-based models. Connected devices facilitate remote monitoring of inventory and performance metrics, supporting predictive maintenance and supply replenishment. Manufacturers are increasingly offering comprehensive service packages that bundle device supplies with software platforms and training programs. This transition from point-product sales to integrated solutions underscores a transformative shift in how healthcare providers procure and deploy biopsy equipment.

Assessing the 2025 US Tariff Implications on Biopsy Devices

The introduction of new tariff schedules in 2025 has reshaped the cost structure of biopsy needle imports into the United States. Tariff escalations on select medical device categories have amplified landed costs for both international manufacturers and domestic distributors. Companies that rely on offshore production have felt the impact most acutely, with cost increases often passed down the supply chain to end users. This environment has prompted a strategic reassessment of sourcing, inventory planning and price positioning.

Supply chain teams are reevaluating manufacturing footprints to mitigate tariff exposure. Some industry players are exploring nearshoring or reshoring options, relocating critical production steps closer to end markets to preserve pricing competitiveness. Others are renegotiating supplier agreements or expanding dual sourcing strategies to safeguard against future policy volatility. Even with these measures, product cost inflation remains a pressing concern for hospitals and surgical centers operating under constrained budgets.

Reimbursement frameworks in the United States have yet to fully adjust to these tariff-induced cost shifts, creating a temporary margin squeeze for device providers. In response, several firms are accelerating their innovation roadmaps to deliver higher-value differentiated products that can justify premium pricing through demonstrated clinical benefits. At the same time, procurement departments in healthcare institutions are increasingly engaging in group purchasing agreements to leverage volume discounts and offset tariff pressures.

Looking ahead, industry leaders anticipate that ongoing trade negotiations and potential tariff exemptions could relieve some of the cost burden. However, the uncertain trajectory of international trade policy underscores the importance of building flexible operational models that can withstand sudden regulatory changes. Stakeholders across the value chain must maintain vigilant monitoring of policy developments and deploy adaptive strategies to protect market positioning and profitability.

Unveiling Layered Market Segmentation Nuances

The market structure reveals distinct dynamics when dissected by device type. Monopty needles have secured widespread adoption for their streamlined design and compatibility with most imaging systems. In contrast, Temno needles offer a robust solution for core tissue extraction, favored in cases demanding larger sample volumes for histopathological analysis. Each variant addresses unique clinical requirements and procedural contexts, influencing purchasing patterns across institutions.

Exploring procedural segmentation highlights divergent growth trajectories. Aspiration biopsy remains integral in cytological evaluations of thyroid, lymph node and soft tissue masses, leveraging negative pressure to extract cellular fluid with minimal invasiveness. Core biopsy, characterized by its ability to capture intact tissue architecture, has become the standard for breast and prostate cancer diagnostics. Vacuum-assisted biopsy technologies have carved out a specialized niche, offering enhanced sample yield and the capacity to target microcalcifications under image guidance.

Product categorization into disposable and reusable offerings illustrates a balance between infection control and cost efficiency. Disposable needles, frequently made of high-grade polymers or metal alloys, address stringent sterilization protocols and workflow simplicity. Reusable options persist in markets with established sterilization infrastructure, where long-term cost savings justify initial investment. Material selection further refines product strategies, with stainless steel and titanium alloys ensuring rigidity and sharpness, while plastic composites deliver lightweight handling and price advantages.

The purchasing landscape is shaped by both traditional procurement channels and digital platforms. Offline sales continue to dominate in established healthcare networks, backed by vendor representatives and service agreements. Meanwhile, online sales portals have emerged as agile alternatives for smaller clinics and ambulatory centers, offering streamlined ordering and rapid delivery. Device applications span a broad spectrum, including breast, kidney, liver, lung and prostate biopsies, each requiring tailored needle geometries and gauge sizes to optimize diagnostic yield.

Finally, segmentation by end user underscores the heterogeneous nature of the market. Ambulatory surgical centers prioritize devices that support high procedural throughput and rapid turnover. Diagnostic clinics seek versatile needle portfolios that accommodate diverse outpatient cases. Hospitals demand comprehensive supplier partnerships that bundle product lines with clinical training, technical support and inventory management. Understanding the interplay among these categories equips stakeholders to align their product offerings with the precise needs of different care settings.

Regional Landscapes Shaping Biopsy Needle Adoption

In the Americas, the biopsy needle market exhibits a mature ecosystem characterized by high healthcare expenditure and advanced clinical protocols. The United States leads demand with sophisticated imaging infrastructure, a robust reimbursement environment and stringent regulatory standards that incentivize premium device performance. Canada follows closely, driven by public healthcare initiatives and regional centers of excellence in oncology. Latin American markets, while smaller in absolute terms, are experiencing accelerated growth as diagnostic capacities expand and access to minimally invasive procedures broadens.

Across Europe, the Middle East and Africa, market trends are shaped by regulatory harmonization efforts and shifting public health priorities. Western Europe demonstrates steady uptake of next-generation needle designs, supported by centralized procurement policies and rigorous clinical validation requirements. In contrast, emerging markets in Eastern Europe and the GCC region reflect a dual-speed trajectory: rising investments in private healthcare drive demand for innovative biopsy solutions, while public-sector systems adopt cost-containment strategies that favor reusable devices and local manufacturing partnerships. Healthcare administrators in Africa are increasingly open to cost-effective devices, though infrastructure limitations remain a key hurdle.

The Asia-Pacific region represents the fastest-growing market segment, propelled by population growth, rising incidence of chronic diseases and expanding healthcare infrastructure. In China, government initiatives to enhance cancer screening programs have boosted demand for core and vacuum-assisted needles. India’s medical device sector benefits from favorable import policies and a growing network of diagnostic centers that adopt minimally invasive techniques. Markets in Southeast Asia and Oceania are also demonstrating robust uptake, with digital procurement platforms easing access to global suppliers and stimulating competitive pricing. This dynamic landscape positions the region as a strategic focal point for manufacturers seeking sustained growth.

Competitive Landscape of Leading Biopsy Needle Innovators

The competitive environment is dominated by established medical device corporations that leverage extensive R&D capabilities and global distribution networks. One prominent player has focused on expanding its portfolio of image-guided needle systems through strategic acquisitions, integrating ultrasound-compatible handles and AI-driven targeting software. Another industry heavyweight has capitalized on modular needle platforms, offering a broad gauge range and interchangeable components to address diverse procedural needs.

Mid-tier companies are carving out specialized niches by concentrating on high-margin segments such as vacuum-assisted technologies and patient-friendly ergonomics. They invest heavily in clinical studies that validate safety and efficacy, securing key endorsements from leading academic centers. This validation bolsters their credibility among interventional radiologists and oncologists, encouraging uptake in both hospital and outpatient settings.

Emerging regional manufacturers are making inroads by offering cost-competitive alternatives tailored to local market requirements. These firms often establish co-development partnerships with healthcare providers to customize needle designs that align with regional procedural preferences and regulatory expectations. Such collaborations accelerate time-to-market and reduce compliance hurdles, making these offerings attractive to budget-constrained facilities.

Supply chain differentiation has become a crucial competitive lever. Several designers now present integrated service models that bundle needle consumables with inventory management systems and remote performance analytics. This shift toward outcome-oriented contracts and subscription-based procurement redefines customer relationships, prompting established suppliers to adopt value-added service strategies to defend market share and drive long-term revenue streams.

Strategic Imperatives for Industry Stakeholders

To thrive in a rapidly evolving biopsy needle market, organizations must prioritize agile innovation and operational resilience. Investing in advanced R&D capabilities is essential to deliver next-generation materials and designs that meet tightening regulatory standards while offering clear clinical advantages. Collaborative partnerships with imaging technology providers and software developers can accelerate the creation of integrated solutions that enhance procedural efficiency and diagnostic accuracy.

Diversifying manufacturing footprints helps mitigate geopolitical and tariff risks, ensuring continuity of supply even amid shifting trade policies. Embracing flexible production models, such as contract manufacturing in multiple regions, affords the agility needed to adjust capacity quickly and optimize cost structures. Transparent supplier relationships and robust supplier audit programs further safeguard quality and compliance across complex supply chains.

Forging strategic alliances with healthcare institutions and key opinion leaders is critical for securing early adoption and clinical validation. Co-design initiatives allow device developers to refine product features in real-world settings, while outcome-focused studies demonstrate value to payers and procurement teams. These collaborations also foster trust and drive advocacy among clinical end users.

Finally, adopting a customer-centric approach to service delivery can differentiate offerings in a crowded marketplace. Bundling device supplies with digital inventory management, training modules and remote technical support creates a comprehensive value proposition that resonates with hospitals, diagnostic centers and ambulatory surgical sites. By aligning with clients’ aspirations for cost containment, patient safety and workflow optimization, industry leaders can fortify partnerships and unlock sustained growth opportunities.

Robust Methodological Framework Underpinning the Analysis

This study employs a rigorous, multi-stage research methodology designed to ensure data integrity and actionable insights. It begins with comprehensive secondary research, drawing on industry journals, regulatory filings and corporate disclosures to map current trends and historical developments. Key regulatory databases and patent repositories augment understanding of innovation trajectories and compliance landscapes. This foundational layer establishes the context for in-depth qualitative and quantitative analysis.

Building on secondary findings, primary research was conducted through structured interviews with cross-functional experts, including biomedical engineers, interventional radiologists and supply chain executives. These conversations provided nuanced perspectives on procedural preferences, procurement challenges and emerging clinical requirements. Responses were validated through cross-comparison with field data to mitigate bias and ensure representative coverage across geographies and care settings.

Quantitative modeling techniques, such as scenario analysis and sensitivity testing, were applied to assess the influence of trade policies, reimbursement changes and technological adoption rates. Data triangulation methods reconciled discrepancies between divergent sources, while internal consistency checks and peer reviews reinforced the study’s reliability. The integration of qualitative insights with robust statistical analysis yielded a holistic view of the market landscape.

The report also leverages a structured validation workshop with industry stakeholders to refine findings and validate strategic recommendations. Feedback from this collaborative forum shaped the final narrative, ensuring that the conclusions and proposed actions resonate with the practical realities faced by manufacturers, distributors and healthcare providers.

Synthesizing Insights for Future Market Trajectories

The biopsy needle sector stands at a pivotal moment, driven by technological convergence, shifting trade dynamics and evolving clinical requirements. Integration of imaging modalities and digital tools promises to elevate diagnostic precision, while emerging material innovations and service-oriented delivery models redefine competitive boundaries. At the same time, tariff measures and regional variances underscore the need for adaptable operational strategies.

Segmentation analysis reveals that success hinges on tailored solutions that address the distinct needs of varied procedural applications, end users and procurement channels. Manufacturers that balance disposability with sustainability, or combine core and vacuum-assisted functionalities in a unified platform, will capture the attention of cost-sensitive and quality-driven stakeholders alike. Regional insights highlight the importance of customizing market entry tactics for mature ecosystems and high-growth territories.

As companies adjust to prevailing trade policies, forging resilient supply networks and demonstrating clear value through clinical evidence will delineate market leaders from the rest. Strategic collaborations with healthcare institutions, combined with a service-enhanced value proposition, will secure long-term customer loyalty. Continuous monitoring of policy shifts and technological breakthroughs will be critical for sustaining momentum over the long term. Organizations that institutionalize horizon-scanning processes and foster a culture of innovation will be best positioned to adapt to unforeseen challenges.

These converging forces point toward a dynamic path where agile innovators and informed decision-makers can unlock new growth avenues while improving patient outcomes. The imperative now is to translate these insights into strategic action, laying the groundwork for sustained success.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Type
    • Monopty Needle
    • Temno Needle
  • Procedure
    • Aspiration Biopsy
    • Core Biopsy
    • Vacuum-Assisted Biopsy
  • Category
    • Disposable
    • Reusable
  • Material
    • Metal
    • Plastic
  • Purchasing Channel
    • Offline Sales
    • Online Sales
  • Application
    • Breast Biopsy
    • Kidney Biopsy
    • Liver Biopsy
    • Lung Biopsy
    • Prostate Biopsy
  • End User
    • Ambulatory Surgical Centers
    • Diagnostic Clinics
    • Hospitals
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Argon Medical Devices, Inc.
  • B. Braun SE
  • Becton, Dickinson and Company
  • Biomedical Srl
  • Boston Scientific Corporation
  • Cardinal Health, Inc.
  • Cook Group Incorporated
  • Doctor Japan Co., Ltd.
  • Freudenberg Medical, LLC
  • Geotek Medical
  • Hologic, Inc.
  • Inrad, Inc.
  • IZI Medical Products
  • Medax Srl
  • Medi-Tech Devices Pvt. Ltd.
  • Medtronic PLC
  • Merit Medical Systems, Inc.
  • Mermaid Medical Group
  • Olympus Corporation
  • Pajunk GmbH Medizintechnologie
  • Point Blank Medical
  • Remington Medical
  • Stryker Corporation
  • Volkmann MedizinTechnik GmbH
  • weLLgo Medical Products GmbH

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Biopsy Needles Market, by Type
8.1. Introduction
8.2. Monopty Needle
8.3. Temno Needle
9. Biopsy Needles Market, by Procedure
9.1. Introduction
9.2. Aspiration Biopsy
9.3. Core Biopsy
9.4. Vacuum-Assisted Biopsy
10. Biopsy Needles Market, by Category
10.1. Introduction
10.2. Disposable
10.3. Reusable
11. Biopsy Needles Market, by Material
11.1. Introduction
11.2. Metal
11.3. Plastic
12. Biopsy Needles Market, by Purchasing Channel
12.1. Introduction
12.2. Offline Sales
12.3. Online Sales
13. Biopsy Needles Market, by Application
13.1. Introduction
13.2. Breast Biopsy
13.3. Kidney Biopsy
13.4. Liver Biopsy
13.5. Lung Biopsy
13.6. Prostate Biopsy
14. Biopsy Needles Market, by End User
14.1. Introduction
14.2. Ambulatory Surgical Centers
14.3. Diagnostic Clinics
14.4. Hospitals
15. Americas Biopsy Needles Market
15.1. Introduction
15.2. United States
15.3. Canada
15.4. Mexico
15.5. Brazil
15.6. Argentina
16. Europe, Middle East & Africa Biopsy Needles Market
16.1. Introduction
16.2. United Kingdom
16.3. Germany
16.4. France
16.5. Russia
16.6. Italy
16.7. Spain
16.8. United Arab Emirates
16.9. Saudi Arabia
16.10. South Africa
16.11. Denmark
16.12. Netherlands
16.13. Qatar
16.14. Finland
16.15. Sweden
16.16. Nigeria
16.17. Egypt
16.18. Turkey
16.19. Israel
16.20. Norway
16.21. Poland
16.22. Switzerland
17. Asia-Pacific Biopsy Needles Market
17.1. Introduction
17.2. China
17.3. India
17.4. Japan
17.5. Australia
17.6. South Korea
17.7. Indonesia
17.8. Thailand
17.9. Philippines
17.10. Malaysia
17.11. Singapore
17.12. Vietnam
17.13. Taiwan
18. Competitive Landscape
18.1. Market Share Analysis, 2024
18.2. FPNV Positioning Matrix, 2024
18.3. Competitive Analysis
18.3.1. Argon Medical Devices, Inc.
18.3.2. B. Braun SE
18.3.3. Becton, Dickinson and Company
18.3.4. Biomedical Srl
18.3.5. Boston Scientific Corporation
18.3.6. Cardinal Health, Inc.
18.3.7. Cook Group Incorporated
18.3.8. Doctor Japan Co., Ltd.
18.3.9. Freudenberg Medical, LLC
18.3.10. Geotek Medical
18.3.11. Hologic, Inc.
18.3.12. Inrad, Inc.
18.3.13. IZI Medical Products
18.3.14. Medax Srl
18.3.15. Medi-Tech Devices Pvt. Ltd.
18.3.16. Medtronic PLC
18.3.17. Merit Medical Systems, Inc.
18.3.18. Mermaid Medical Group
18.3.19. Olympus Corporation
18.3.20. Pajunk GmbH Medizintechnologie
18.3.21. Point Blank Medical
18.3.22. Remington Medical
18.3.23. Stryker Corporation
18.3.24. Volkmann MedizinTechnik GmbH
18.3.25. weLLgo Medical Products GmbH
19. ResearchAI
20. ResearchStatistics
21. ResearchContacts
22. ResearchArticles
23. Appendix
List of Figures
FIGURE 1. BIOPSY NEEDLES MARKET MULTI-CURRENCY
FIGURE 2. BIOPSY NEEDLES MARKET MULTI-LANGUAGE
FIGURE 3. BIOPSY NEEDLES MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL BIOPSY NEEDLES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2024 VS 2030 (%)
FIGURE 16. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 18. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 20. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. AMERICAS BIOPSY NEEDLES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. AMERICAS BIOPSY NEEDLES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. UNITED STATES BIOPSY NEEDLES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 24. UNITED STATES BIOPSY NEEDLES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. EUROPE, MIDDLE EAST & AFRICA BIOPSY NEEDLES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. EUROPE, MIDDLE EAST & AFRICA BIOPSY NEEDLES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. ASIA-PACIFIC BIOPSY NEEDLES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 28. ASIA-PACIFIC BIOPSY NEEDLES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 29. BIOPSY NEEDLES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 30. BIOPSY NEEDLES MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. BIOPSY NEEDLES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BIOPSY NEEDLES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY MONOPTY NEEDLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY TEMNO NEEDLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY ASPIRATION BIOPSY, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY CORE BIOPSY, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY VACUUM-ASSISTED BIOPSY, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY DISPOSABLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY REUSABLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY METAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY PLASTIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY OFFLINE SALES, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY ONLINE SALES, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY BREAST BIOPSY, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY KIDNEY BIOPSY, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY LIVER BIOPSY, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY LUNG BIOPSY, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY PROSTATE BIOPSY, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY DIAGNOSTIC CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL BIOPSY NEEDLES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS BIOPSY NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS BIOPSY NEEDLES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 40. UNITED STATES BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 41. UNITED STATES BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 42. UNITED STATES BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 43. UNITED STATES BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 44. UNITED STATES BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2018-2030 (USD MILLION)
TABLE 45. UNITED STATES BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 46. UNITED STATES BIOPSY NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 47. UNITED STATES BIOPSY NEEDLES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 48. CANADA BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 49. CANADA BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 50. CANADA BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 51. CANADA BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 52. CANADA BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2018-2030 (USD MILLION)
TABLE 53. CANADA BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 54. CANADA BIOPSY NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 55. MEXICO BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 56. MEXICO BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 57. MEXICO BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 58. MEXICO BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 59. MEXICO BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2018-2030 (USD MILLION)
TABLE 60. MEXICO BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 61. MEXICO BIOPSY NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 62. BRAZIL BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 63. BRAZIL BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 64. BRAZIL BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 65. BRAZIL BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 66. BRAZIL BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2018-2030 (USD MILLION)
TABLE 67. BRAZIL BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 68. BRAZIL BIOPSY NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 69. ARGENTINA BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 70. ARGENTINA BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 71. ARGENTINA BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 72. ARGENTINA BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 73. ARGENTINA BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2018-2030 (USD MILLION)
TABLE 74. ARGENTINA BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 75. ARGENTINA BIOPSY NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 76. EUROPE, MIDDLE EAST & AFRICA BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 77. EUROPE, MIDDLE EAST & AFRICA BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 78. EUROPE, MIDDLE EAST & AFRICA BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 79. EUROPE, MIDDLE EAST & AFRICA BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 80. EUROPE, MIDDLE EAST & AFRICA BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2018-2030 (USD MILLION)
TABLE 81. EUROPE, MIDDLE EAST & AFRICA BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 82. EUROPE, MIDDLE EAST & AFRICA BIOPSY NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 83. EUROPE, MIDDLE EAST & AFRICA BIOPSY NEEDLES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 84. UNITED KINGDOM BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 85. UNITED KINGDOM BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 86. UNITED KINGDOM BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 87. UNITED KINGDOM BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 88. UNITED KINGDOM BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2018-2030 (USD MILLION)
TABLE 89. UNITED KINGDOM BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 90. UNITED KINGDOM BIOPSY NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 91. GERMANY BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 92. GERMANY BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 93. GERMANY BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 94. GERMANY BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 95. GERMANY BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2018-2030 (USD MILLION)
TABLE 96. GERMANY BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 97. GERMANY BIOPSY NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 98. FRANCE BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 99. FRANCE BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 100. FRANCE BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 101. FRANCE BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 102. FRANCE BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2018-2030 (USD MILLION)
TABLE 103. FRANCE BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 104. FRANCE BIOPSY NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 105. RUSSIA BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 106. RUSSIA BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 107. RUSSIA BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 108. RUSSIA BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 109. RUSSIA BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2018-2030 (USD MILLION)
TABLE 110. RUSSIA BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 111. RUSSIA BIOPSY NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 112. ITALY BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 113. ITALY BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 114. ITALY BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 115. ITALY BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 116. ITALY BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2018-2030 (USD MILLION)
TABLE 117. ITALY BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 118. ITALY BIOPSY NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 119. SPAIN BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 120. SPAIN BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 121. SPAIN BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 122. SPAIN BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 123. SPAIN BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2018-2030 (USD MILLION)
TABLE 124. SPAIN BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 125. SPAIN BIOPSY NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 126. UNITED ARAB EMIRATES BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 127. UNITED ARAB EMIRATES BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 128. UNITED ARAB EMIRATES BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 129. UNITED ARAB EMIRATES BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 130. UNITED ARAB EMIRATES BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2018-2030 (USD MILLION)
TABLE 131. UNITED ARAB EMIRATES BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 132. UNITED ARAB EMIRATES BIOPSY NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 133. SAUDI ARABIA BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 134. SAUDI ARABIA BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 135. SAUDI ARABIA BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 136. SAUDI ARABIA BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 137. SAUDI ARABIA BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2018-2030 (USD MILLION)
TABLE 138. SAUDI ARABIA BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 139. SAUDI ARABIA BIOPSY NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 140. SOUTH AFRICA BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 141. SOUTH AFRICA BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 142. SOUTH AFRICA BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 143. SOUTH AFRICA BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 144. SOUTH AFRICA BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2018-2030 (USD MILLION)
TABLE 145. SOUTH AFRICA BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 146. SOUTH AFRICA BIOPSY NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 147. DENMARK BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 148. DENMARK BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 149. DENMARK BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 150. DENMARK BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 151. DENMARK BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2018-2030 (USD MILLION)
TABLE 152. DENMARK BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 153. DENMARK BIOPSY NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 154. NETHERLANDS BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 155. NETHERLANDS BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 156. NETHERLANDS BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 157. NETHERLANDS BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 158. NETHERLANDS BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2018-2030 (USD MILLION)
TABLE 159. NETHERLANDS BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 160. NETHERLANDS BIOPSY NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 161. QATAR BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 162. QATAR BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 163. QATAR BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 164. QATAR BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 165. QATAR BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2018-2030 (USD MILLION)
TABLE 166. QATAR BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 167. QATAR BIOPSY NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 168. FINLAND BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 169. FINLAND BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 170. FINLAND BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 171. FINLAND BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 172. FINLAND BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2018-2030 (USD MILLION)
TABLE 173. FINLAND BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 174. FINLAND BIOPSY NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 175. SWEDEN BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 176. SWEDEN BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 177. SWEDEN BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 178. SWEDEN BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 179. SWEDEN BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2018-2030 (USD MILLION)
TABLE 180. SWEDEN BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 181. SWEDEN BIOPSY NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 182. NIGERIA BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 183. NIGERIA BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 184. NIGERIA BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 185. NIGERIA BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 186. NIGERIA BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2018-2030 (USD MILLION)
TABLE 187. NIGERIA BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 188. NIGERIA BIOPSY NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 189. EGYPT BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 190. EGYPT BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 191. EGYPT BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 192. EGYPT BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 193. EGYPT BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2018-2030 (USD MILLION)
TABLE 194. EGYPT BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 195. EGYPT BIOPSY NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 196. TURKEY BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 197. TURKEY BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 198. TURKEY BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 199. TURKEY BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 200. TURKEY BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2018-2030 (USD MILLION)
TABLE 201. TURKEY BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 202. TURKEY BIOPSY NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 203. ISRAEL BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 204. ISRAEL BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 205. ISRAEL BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 206. ISRAEL BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 207. ISRAEL BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2018-2030 (USD MILLION)
TABLE 208. ISRAEL BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 209. ISRAEL BIOPSY NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 210. NORWAY BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 211. NORWAY BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 212. NORWAY BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 213. NORWAY BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 214. NORWAY BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2018-2030 (USD MILLION)
TABLE 215. NORWAY BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 216. NORWAY BIOPSY NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 217. POLAND BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 218. POLAND BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 219. POLAND BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 220. POLAND BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 221. POLAND BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2018-2030 (USD MILLION)
TABLE 222. POLAND BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 223. POLAND BIOPSY NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 224. SWITZERLAND BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 225. SWITZERLAND BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 226. SWITZERLAND BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 227. SWITZERLAND BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 228. SWITZERLAND BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2018-2030 (USD MILLION)
TABLE 229. SWITZERLAND BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 230. SWITZERLAND BIOPSY NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 231. ASIA-PACIFIC BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 232. ASIA-PACIFIC BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 233. ASIA-PACIFIC BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 234. ASIA-PACIFIC BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 235. ASIA-PACIFIC BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2018-2030 (USD MILLION)
TABLE 236. ASIA-PACIFIC BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 237. ASIA-PACIFIC BIOPSY NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 238. ASIA-PACIFIC BIOPSY NEEDLES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 239. CHINA BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 240. CHINA BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 241. CHINA BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 242. CHINA BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 243. CHINA BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2018-2030 (USD MILLION)
TABLE 244. CHINA BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 245. CHINA BIOPSY NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 246. INDIA BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 247. INDIA BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 248. INDIA BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 249. INDIA BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 250. INDIA BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2018-2030 (USD MILLION)
TABLE 251. INDIA BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 252. INDIA BIOPSY NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 253. JAPAN BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 254. JAPAN BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 255. JAPAN BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 256. JAPAN BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 257. JAPAN BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2018-2030 (USD MILLION)
TABLE 258. JAPAN BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 259. JAPAN BIOPSY NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 260. AUSTRALIA BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 261. AUSTRALIA BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 262. AUSTRALIA BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 263. AUSTRALIA BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 264. AUSTRALIA BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2018-2030 (USD MILLION)
TABLE 265. AUSTRALIA BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 266. AUSTRALIA BIOPSY NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 267. SOUTH KOREA BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 268. SOUTH KOREA BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 269. SOUTH KOREA BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 270. SOUTH KOREA BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 271. SOUTH KOREA BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2018-2030 (USD MILLION)
TABLE 272. SOUTH KOREA BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 273. SOUTH KOREA BIOPSY NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 274. INDONESIA BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 275. INDONESIA BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 276. INDONESIA BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 277. INDONESIA BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 278. INDONESIA BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2018-2030 (USD MILLION)
TABLE 279. INDONESIA BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 280. INDONESIA BIOPSY NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 281. THAILAND BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 282. THAILAND BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 283. THAILAND BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 284. THAILAND BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 285. THAILAND BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2018-2030 (USD MILLION)
TABLE 286. THAILAND BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 287. THAILAND BIOPSY NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 288. PHILIPPINES BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 289. PHILIPPINES BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 290. PHILIPPINES BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 291. PHILIPPINES BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 292. PHILIPPINES BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2018-2030 (USD MILLION)
TABLE 293. PHILIPPINES BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 294. PHILIPPINES BIOPSY NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 295. MALAYSIA BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 296. MALAYSIA BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 297. MALAYSIA BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 298. MALAYSIA BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 299. MALAYSIA BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2018-2030 (USD MILLION)
TABLE 300. MALAYSIA BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 301. MALAYSIA BIOPSY NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 302. SINGAPORE BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 303. SINGAPORE BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 304. SINGAPORE BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 305. SINGAPORE BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 306. SINGAPORE BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2018-2030 (USD MILLION)
TABLE 307. SINGAPORE BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 308. SINGAPORE BIOPSY NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 309. VIETNAM BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 310. VIETNAM BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 311. VIETNAM BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 312. VIETNAM BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 313. VIETNAM BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2018-2030 (USD MILLION)
TABLE 314. VIETNAM BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 315. VIETNAM BIOPSY NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 316. TAIWAN BIOPSY NEEDLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 317. TAIWAN BIOPSY NEEDLES MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 318. TAIWAN BIOPSY NEEDLES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 319. TAIWAN BIOPSY NEEDLES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 320. TAIWAN BIOPSY NEEDLES MARKET SIZE, BY PURCHASING CHANNEL, 2018-2030 (USD MILLION)
TABLE 321. TAIWAN BIOPSY NEEDLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 322. TAIWAN BIOPSY NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 323. BIOPSY NEEDLES MARKET SHARE, BY KEY PLAYER, 2024
TABLE 324. BIOPSY NEEDLES MARKET, FPNV POSITIONING MATRIX, 2024

Companies Mentioned

The companies profiled in this Biopsy Needles market report include:
  • Argon Medical Devices, Inc.
  • B. Braun SE
  • Becton, Dickinson and Company
  • Biomedical Srl
  • Boston Scientific Corporation
  • Cardinal Health, Inc.
  • Cook Group Incorporated
  • Doctor Japan Co., Ltd.
  • Freudenberg Medical, LLC
  • Geotek Medical
  • Hologic, Inc.
  • Inrad, Inc.
  • IZI Medical Products
  • Medax Srl
  • Medi-Tech Devices Pvt. Ltd.
  • Medtronic PLC
  • Merit Medical Systems, Inc.
  • Mermaid Medical Group
  • Olympus Corporation
  • Pajunk GmbH Medizintechnologie
  • Point Blank Medical
  • Remington Medical
  • Stryker Corporation
  • Volkmann MedizinTechnik GmbH
  • weLLgo Medical Products GmbH

Methodology

Loading
LOADING...

Table Information